Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution

Journal: Nature Genetics

Published: 2020-03-05

DOI: 10.1038/s41588-020-0584-7

Affiliations: 52

Authors: 268

Go to article
Institutions Share
UCL, United Kingdom (UK) 0.16
The Francis Crick Institute, United Kingdom (UK) 0.11
University College London Hospitals NHS Foundation Trust (UCLH), United Kingdom (UK) 0.10
Wythenshawe Hospital, MFT, United Kingdom (UK) 0.07
Royal Brompton and Harefield NHS Foundation Trust, United Kingdom (UK) 0.07
Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom (UK) 0.05
University Hospitals Birmingham NHS Foundation Trust (UHB), United Kingdom (UK) 0.04
Aberdeen Royal Infirmary, NHS Grampian, United Kingdom (UK) 0.03
University of Leicester, United Kingdom (UK) 0.03
Cancer Research UK and UCL Cancer Trials Centre (UCL CTC), United Kingdom (UK) 0.03
University Hospitals of Leicester NHS Trust (UHL), United Kingdom (UK) 0.03
The Christie NHS Foundation Trust, United Kingdom (UK) 0.03
Cancer Research UK Manchester Institute, UoM, United Kingdom (UK) 0.02
Barts Health NHS Trust, United Kingdom (UK) 0.02
University Hospital Southampton NHS Foundation Trust, United Kingdom (UK) 0.02
Manchester Cancer Research Centre (MCRC), United Kingdom (UK) 0.02
Golden Jubilee National Hospital, NHSGGC, United Kingdom (UK) 0.02
Cardiff & Vale University Health Board, United Kingdom (UK) 0.02
Princess Alexandra Hospital NHS Trust, United Kingdom (UK) 0.01
Liverpool Heart and Chest Hospital, United Kingdom (UK) 0.01
CRUK Lung Cancer Centre of Excellence, United Kingdom (UK) 0.01
NHS Greater Glasgow and Clyde (NHSGGC), United Kingdom (UK) 0.01
The Whittington Hospital, Whittington Health NHS, United Kingdom (UK) 0.01
Eötvös Loránd University (ELTE), Hungary 0.01
NIHR Leicester Respiratory Biomedical Research Unit (BRU), United Kingdom (UK) 0.01
Ashford and St Peter's Hospitals NHS Foundation Trust, United Kingdom (UK) 0.01
Independent Cancer Patients' Voice (ICPV), United Kingdom (UK) 0.01
Barnet Hospital, Royal Free London NHS Foundation Trust, United Kingdom (UK) 0.01
The Rockefeller University, United States of America (USA) 0
Velindre Cancer Centre, Velindre NHS Trust, United Kingdom (UK) 0
Danish Cancer Society, Denmark 0
University College Hospital (UCH), United Kingdom (UK) 0
Biomedical Sciences Group, KU Leuven, Belgium 0
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0
Ziekenhuis Netwerk Antwerpen (ZNA), Belgium 0
GasthuisZusters Antwerpen (GZA), Belgium 0
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0
DKTK Partner Site Berlin, Germany 0
Aarhus University Hospital, Denmark 0
Max Delbrück Center for Molecular Medicine (MDC), Germany 0
Netherlands Cancer Institute (NKI), Netherlands 0
Brigham and Women's Hospital (BWH), United States of America (USA) 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER